Comparative Interactome Analysis of α-arrestin Families in Human and Drosophila

Reviewer #1 (Public Review):

The study provides a complete comparative interactome analysis of α-arrestin in both humans and drosophila. The authors have presented interactomes of six humans and twelve Drosophila α-arrestins using affinity purification/mass spectrometry (AP/MS). The constructed interactomes helped to find α-arrestins binding partners through common protein motifs. The authors have used bioinformatic tools and experimental data in human cells to identify the roles of TXNIP and ARRDC5: TXNIP-HADC2 interaction and ARRDC5-V-type ATPase interaction. The study reveals the PPI network for α-arrestins and examines the functions of α-arrestins in both humans and Drosophila.

Comments
I will like to congratulate the authors and the corresponding authors of this manuscript for bringing together such an elaborate study on α-arrestin and conducting a comparative study in drosophila and humans.

Introduction:
The introduction provides a rationale behind why the comparison between humans and Drosophila is carried out.
- Even though this is a research manuscript, including existing literature on similar comparison of α-arrestin from other articles will invite a wide readership.

Results:
The results cover all the necessary points concluded from the experiments and computational analysis.
• The authors could point out the similarity of the α-arrestin in both humans and Drosophila.
• Citing the direct connecting genes from the network in the text will invite citations and a wider readership.

Figures:
The images are elaborate and well-made.
• The authors could use a direct connected gene-gene network that pointing interactions. This can be used by other readers working on the same topic and ensure reproducibility and citations.
• The blot/gel images can be of higher resolution.

Discussion:
The authors have utilized and discussed the conclusion they draw from their study. But could highlight more on ARRDCs and why it was selected out of the other arrestins. The authors have provided future work directions associated with their work.

Supplementary figures:
The authors have a rigorous amount of work added together for the success of this manuscript.

Reviewer #2 (Public Review):

In this manuscript, the authors present a novel interactome focused on human and fly alpha-arrestin family proteins and demonstrate its application in understanding the functions of these proteins. Initially, the authors employed AP/MS analysis, a popular method for mapping protein-protein interactions (PPIs) by isolating protein complexes. Through rigorous statistical and manual quality control procedures, they established two robust interactomes, consisting of 6 baits and 307 prey proteins for humans, and 12 baits and 467 prey proteins for flies. To gain insights into the gene function, the authors investigated the interactors of alpha-arrestin proteins through various functional analyses, such as gene set enrichment. Furthermore, by comparing the interactors between humans and flies, the authors described both conserved and species-specific functions of the alpha-arrestin proteins. To validate their findings, the authors performed several experimental validations for TXNIP and ARRDC5 using ATAC-seq, siRNA knockdown, and tissue staining assays. The experimental results strongly support the predicted functions of the alpha-arrestin proteins and underscore their importance.

Reviewer #3 (Public Review):

Lee, Kyungtae and colleagues have discovered and mapped out alpha-arrestin interactomes in both human and Drosophila through the affinity purification/mass spectrometry and the SAINTexpress method. They found the high confident interactomes, consisting of 390 protein-protein interactions (PPIs) between six human alpha-arrestins and 307 preproteins, as well as 740 PPIs between twelve Drosophila alpha-arrestins and 467 prey proteins. To define and characterize these identified alpha-arrestin interactomes, the team employed a variety of widely recognized bioinformatics tools. These included protein domain enrichment analysis, PANTHER for protein class enrichment, DAVID for subcellular localization analysis, COMPLEAT for the identification of functional complexes, and DIOPT to identify evolutionary conserved interactomes. Through these analyses, they confirmed known alpha-arrestin interactors' role and associated functions such as ubiquitin ligase and protease. Furthermore, they found unexpected biological functions in the newly discovered interactomes, including RNA splicing and helicase, GTPase-activating proteins, ATP synthase. The authors carried out further study into the role of human TXNIP in transcription and epigenetic regulation, as well as the role of ARRDC5 in osteoclast differentiation. This study holds important value as the newly identified alpha-arrestin interactomes are likely aiding functional studies of this group of proteins. Despite the overall support from data for the paper's conclusions, certain elements related to data quantification, interpretation, and presentation demand more detailed explanation and clarification.

1. In Figure 1B, it is shown that human alpha-arrestins were N-GFP tagged (N-terminal) and Drosophila alpha-arrestins were C-GFP (C-terminal). However, the rationale of why the authors used different tags for human and fly proteins was not explained in the main text and methods.
2. In Figure 2A, there seems to be an error for labeling the GAL4p/GAL80p complex that includes NOTCH2, NOTCH1 and TSC2.
3. In Figure 5, given that knockdown of TXNIP did not affect the levels and nuclear localization of HDAC2, the authors suggest that TXNIP might modulate HDAC2 activity. However, the ChiP assay suggest a different model - TXNIP-HDAC2 interaction might inhibit the chromatin occupancy of HDAC2, reducing histone deacetylation and increasing global chromatin accessibly. The authors need to propose a model consistent with these sets of all data.
4. The authors showed that ectopic expression of ARRDC5 increased osteoclast differentiation and function. Does loss of ARDDC5 lead to defects in osteoclast function and fate determination?
5. From Figure 6D, the authors argued that ARRDC5 overexpression resulted in more V-ATPase signals: however, there is no quantification. Quantification of the confocal images will foster the conclusion. Also, western blots for V-ATPase proteins will provide an alternative way to determine the effects of ARRDC5.
6. The results from Figure 6D did not support the authors' argument that ARRDC5 might control the membrane localization of the V-ATPase, as bafilomycin is the V-ATPase inhibitor. ARRDC5 knockdown experiments will help to determine whether ARRDC5 can control the membrane localization of the V-ATPase in osteoclast.